1-benzyl-5-piperazin-1-yl-3,4 dihydro1H-quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(D) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-HT) for the treatment of diseases of the central nervous system

Details for Australian Patent Application No. 2005205016 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Sui, Meng; Zhao, Shu-Hai

Agent Spruson & Ferguson

Pub. Number AU-B-2005205016

PCT Pub. Number WO2005/067933

Priority 60/537,080 16.01.04 US

Filing date 7 January 2005

Wipo publication date 28 July 2005

Acceptance publication date 15 July 2010

International Classifications

C07D 239/80 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/536 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems

A61K 31/5415 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

C07D 265/18 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 285/16 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/067933 Priority application(s): WO2005/067933

15 July 2010 Application Accepted

  Published as AU-B-2005205016

11 November 2010 Standard Patent Sealed

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205031-Formulation for treating obesity and associated metabolic syndrome

2005204993-Air conditioning system for a motor vehicle